The Health Ministry proposes amendments to the Drugs Rules, 1945, introducing separate licences for bulk drug wholesalers to strengthen regulatory oversight.

NEW DELHI: The Union Ministry of Health and Family Welfare has proposed a separate licensing framework for the wholesale distribution of bulk drugs, including active and inactive pharmaceutical ingredients, through amendments to the Drugs Rules, 1945.
The proposed changes, outlined in Draft Gazette Notification G.S.R. No. 987 (E), dated November 2, 2026, seek to introduce a dedicated application form, Form 19-BC, and a separate licence, Form 20-BC, for bulk drug wholesalers. The proposed system would distinguish the licensing requirements for bulk drugs from those currently applicable to pharmaceutical formulations.
At present, a common licence covers the wholesale distribution of both pharmaceutical formulations and bulk drugs. The proposed amendments seek to establish a dedicated regulatory mechanism for bulk drugs, with the objective of strengthening oversight and ensuring greater accountability throughout the pharmaceutical supply chain.
The proposal was approved by the Drugs Consultative Committee (DCC) at its 67th meeting on November 17, 2025, and subsequently by the Drugs Technical Advisory Board (DTAB) at its 93rd meeting on February 16, 2026.
Under the proposed framework, licences will specify the categories of bulk drugs handled by wholesalers, including substances regulated under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985.
The wholesale sale of bulk drugs will also have to be conducted under the personal supervision of a competent person. The requirement is intended to strengthen accountability and improve monitoring of the distribution and handling of pharmaceutical substances.
According to the Ministry, the proposed changes are aimed at improving regulatory control over bulk drug distribution, strengthening enforcement measures relating to antimicrobial resistance and monitoring the movement of substances covered under the NDPS Act.
The amendments would make it mandatory for wholesalers dealing in bulk drugs to obtain a separate licence for their operations.
To facilitate a smooth transition, existing licence holders will be provided adequate time to meet the revised requirements. The new provisions will become applicable to them upon the expiry of their existing licence retention period or 12 months after the final publication of the amendment, whichever is later.
The Ministry has invited objections and suggestions from stakeholders and members of the public on the draft amendments. Submissions may be made within 30 days from the date on which copies of the Gazette notification containing the draft rules are made available to the public.
The proposed framework is expected to introduce a more specific licensing structure for bulk drug wholesalers and strengthen regulatory monitoring across India's pharmaceutical distribution network.